Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
Global Cell Viability Assays Market Report 2024

Cell Viability Assays Global Market Report 2024 – By Product (Consumables, Instruments), By Application (Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications), By End-User (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

Cell Viability Assays Global Market Report 2024

Starting Price : $5000.00 | Pages : 175 | Published : July 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data
FAQs

Need assistance or more information before the purchase?

Enquire Before Buying
Cell Viability Assays Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Cell Viability Assays Market Definition And Segments

Cell viability assays are methods used to determine the ability of cells, tissues, or organs to maintain or recover a state of survival. Cell viability assays are used to evaluate the best growth conditions for cells in culture in response to external stimuli, chemicals, and medicinal treatments when determining optimal growth conditions in cell culture.

The main products of cell viability assays are consumables and instruments. Consumables in cell viability assays are things that are used only once or need to be replaced on a regular basis. They are used for various applications including basic research, stem cell research, drug discovery and development, clinical and diagnostic applications, and others by academic and research institutes, pharmaceutical and biotechnology companies, hospital and diagnostic laboratories, and others.

The cell viability assays market covered in this report is segmented –

1) By Product: Consumables, Instruments

2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications

3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users

The cell viability assays market size has grown rapidly in recent years. It will grow from $1.41 billion in 2023 to $1.56 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased investment in cancer research, growth in pharmaceutical R&D expenditure, growth in the biotechnology sector, increased advancements in cell culture techniques, rise in demand for stem cell research, rise in the need for toxicity testing, rise in the utilization of real time cell analysis systems, rise in the number of CROs (contract research organizations).

The cell viability assays market size is expected to see rapid growth in the next few years. It will grow to $2.34 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rise in government funding for cell based research, increasing focus on precision medicine, growth in stem cell research and applications, increasing availability of automated cell viability analyzers, rise in the incidence of infectious diseases, increasing focus on improving assay accuracy and sensitivity, increasing awareness about the benefits of cell viability assays, rise in the development of organ on a chip technologies, increasing demand for regenerative medicine. Major trends in the forecast period include advancement in high throughput screening methods, implementation of AI and machine learning algorithms, development of real time monitoring systems, adoption of automated liquid handling systems, development of multiplex assays to simultaneously measure cell viability, adoption of more sustainable and eco-friendly reagents, development of user friendly assay kits, advancement in electrochemical assays, implementation of scalable cell viability assays, development of assays compatible with primary cells and stem cells.

Role Of Cell-Based Therapeutics In Driving The Growth Of The Cell Viability Assays Market

The increasing cell-based therapeutics is expected to propel the growth of the cell viability assay market going forward. Cell-based therapeutics refer to treatments that use living cells to repair or replace damaged tissue, treat diseases, or restore normal function. Cell-based therapeutics are fueled by advances in biotechnology, increasing investment in regenerative medicine, growing acceptance and adoption of cell therapies, and improvements in cell engineering and manufacturing technologies. Cell viability assays support cell-based therapeutics by ensuring the health, functionality, and safety of therapeutic cells, thereby optimizing treatment efficacy and quality control. For instance, according to the American Society of Gene & Cell Therapy, a US-based non-profit medical and scientific organization, 38 trials were initiated for non-genetically modified cell therapies in Q1 2023, 7 more than the previous quarter, Q4 2022. Therefore, increasing cell-based therapeutics is driving the growth of the cell viability assay market.

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.

Innovative Cell Screening Technologies Revolutionize Drug Discovery

Major companies operating in the cell viability assays market are developing innovative cell screening technologies to improve accuracy and speed up drug discovery. Cell screening technologies enhance cell viability assays by enabling high-throughput, precise, and rapid analysis of cell health and responses, thus optimizing experimental conditions and improving the development of therapeutic strategies. For instance, in May 2024, Arralyze, a Germany-based technology company, introduced CellShepherd, a cutting-edge platform for single-cell analysis. It utilizes proprietary nanowell glass arrays to miniaturize cell-based assays for real-time monitoring. The autonomous system offers precise cell dispensing, co-culturing in sterile conditions, and imaging with brightfield and fluorescent channels. The AI-driven analysis guarantees accurate cell counting and tracking. This user-friendly platform addresses the increasing need for precise single-cell research in biomedical and life science applications.

BD Biosciences' Strategic Acquisition of Cytognos to Enhance Blood Cancer Diagnostics and Immune Monitoring Portfolio

In February 2022, BD Biosciences, a US-based medical device company, acquired Cytognos for an undisclosed amount. The acquisition aims to expand BD’s portfolio in blood cancer diagnostics, minimal residual disease (MRD) detection, and immune monitoring research. Cytognos S.L. is a Spain-based biotechnology company that provides cell viability assays, including clinical flow cytometry solutions.

North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell viability assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cell viability assays market consists of revenues earned by entities by providing services such as assay development services, assay validation services, cell culture services, and data analysis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The cell viability assays market also includes sales of microscopes, imaging systems, incubators, plate readers, and automated liquid handling systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The cell viability assays market research report is one of a series of new reports from The Business Research Company that provides cell viability assays market statistics, including the cell viability assays industry global market size, regional shares, competitors with cell viability assays market share, detailed cell viability assays market segments, market trends, and opportunities, and any further data you may need to thrive in the cell viability assays industry. These cell viability assays market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Cell Viability Assays Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $1.56 billion
Revenue Forecast In 2033 $2.34 billion
Growth Rate CAGR of 10.6% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Product: Consumables, Instruments
2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications
3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc., Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Cell Viability Assays Market Characteristics

    3. Cell Viability Assays Market Trends And Strategies

    4. Cell Viability Assays Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Cell Viability Assays Market Size and Growth

    5.1. Global Cell Viability Assays Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Cell Viability Assays Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Cell Viability Assays Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Cell Viability Assays Market Segmentation

    6.1. Global Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Consumables

    Instruments

    6.2. Global Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Basic Research

    Stem Cell Research

    Drug Discovery And Development

    Clinical And Diagnostic Applications

    Other Applications

    6.3. Global Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Academic And Research Institutes

    Pharmaceutical And Biotechnology Companies

    Hospital And Diagnostic Laboratories

    Other End-Users

    7. Cell Viability Assays Market Regional And Country Analysis

    7.1. Global Cell Viability Assays Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Cell Viability Assays Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Cell Viability Assays Market

    8.1. Asia-Pacific Cell Viability Assays Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Cell Viability Assays Market

    9.1. China Cell Viability Assays Market Overview

    9.2. China Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Cell Viability Assays Market

    10.1. India Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Cell Viability Assays Market

    11.1. Japan Cell Viability Assays Market Overview

    11.2. Japan Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Cell Viability Assays Market

    12.1. Australia Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Cell Viability Assays Market

    13.1. Indonesia Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Cell Viability Assays Market

    14.1. South Korea Cell Viability Assays Market Overview

    14.2. South Korea Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Cell Viability Assays Market

    15.1. Western Europe Cell Viability Assays Market Overview

    15.2. Western Europe Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Cell Viability Assays Market

    16.1. UK Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Cell Viability Assays Market

    17.1. Germany Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Cell Viability Assays Market

    18.1. France Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Cell Viability Assays Market

    19.1. Italy Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Cell Viability Assays Market

    20.1. Spain Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Cell Viability Assays Market

    21.1. Eastern Europe Cell Viability Assays Market Overview

    21.2. Eastern Europe Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Cell Viability Assays Market

    22.1. Russia Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Cell Viability Assays Market

    23.1. North America Cell Viability Assays Market Overview

    23.2. North America Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Cell Viability Assays Market

    24.1. USA Cell Viability Assays Market Overview

    24.2. USA Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Cell Viability Assays Market

    25.1. Canada Cell Viability Assays Market Overview

    25.2. Canada Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Cell Viability Assays Market

    26.1. South America Cell Viability Assays Market Overview

    26.2. South America Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Cell Viability Assays Market

    27.1. Brazil Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Cell Viability Assays Market

    28.1. Middle East Cell Viability Assays Market Overview

    28.2. Middle East Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Cell Viability Assays Market

    29.1. Africa Cell Viability Assays Market Overview

    29.2. Africa Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Cell Viability Assays Market Competitive Landscape And Company Profiles

    30.1. Cell Viability Assays Market Competitive Landscape

    30.2. Cell Viability Assays Market Company Profiles

    30.2.1. Thermo Fisher Scientific Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Danaher Corporation

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Merck KGaA

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Becton, Dickinson, and Company

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Agilent Technologies Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Cell Viability Assays Market Other Major And Innovative Companies

    31.1. Lonza Group Ltd.

    31.2. PerkinElmer Inc.

    31.3. Sartorius AG

    31.4. Charles River Laboratories

    31.5. Bio-Rad Laboratories Inc.

    31.6. Bio-Techne Corporation

    31.7. Beckman Coulter Inc.

    31.8. Promega Corporation

    31.9. Abcam Limited

    31.10. MP Biomedicals

    31.11. Cayman Chemical Company

    31.12. Cell Signaling Technology Inc.

    31.13. Enzo Biochem Inc.

    31.14. Creative Bioarray

    31.15. Abnova Corporation

    32. Global Cell Viability Assays Market Competitive Benchmarking

    33. Global Cell Viability Assays Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Cell Viability Assays Market

    35. Cell Viability Assays Market Future Outlook and Potential Analysis

    35.1 Cell Viability Assays Market In 2028 - Countries Offering Most New Opportunities

    35.2 Cell Viability Assays Market In 2028 - Segments Offering Most New Opportunities

    35.3 Cell Viability Assays Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Cell Viability Assays Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Cell Viability Assays Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Thermo Fisher Scientific Inc. Financial Performance
  • Table 75: Danaher Corporation Financial Performance
  • Table 76: Merck KGaA Financial Performance
  • Table 77: Becton, Dickinson, and Company Financial Performance
  • Table 78: Agilent Technologies Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Cell Viability Assays Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Cell Viability Assays Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Cell Viability Assays Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Cell Viability Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Cell Viability Assays Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 75: Danaher Corporation Financial Performance
  • Figure 76: Merck KGaA Financial Performance
  • Figure 77: Becton, Dickinson, and Company Financial Performance
  • Figure 78: Agilent Technologies Inc. Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Cell And Gene Therapy Market 2021 - By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Cellular M2M Global Market Report 2024 – By Services (Connectivity Services, Professional Services, Managed Services), By Organization Size (Large Enterprises, Small And Medium Enterprises (SMEs)), By Application (Asset Tracking And Monitoring, Predictive Maintenance, Telemedicine, Fleet Management, Warehouse Management, Industrial Automation, Smart Meter, Other Applications), By End-User (Healthcare, Energy And Utilities, Transportation And Logistics, Manufacturing, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Live Cell Imaging Global Market Report 2024 – By Product (Equipment, Consumable, Software), By Technology (Time-Lapse Microscopy, Fluorescence Recovery After Photobleaching (FRAP), Fluorescence Resonance Energy Transfer (FRET), High Content Screening (HCS), Other Technologies), By Application (Cell Biology, Developmental Biology, Stem Cell and Drug Discovery, Other Applications), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations (CROs)) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell Therapy Global Market Report 2024 – By Technique (Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy), By Therapy Type (Allogeneic Therapies, Autologous Therapies), By Application (Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Stem Cell Therapy Global Market Report 2024 – By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), By Application (Musculoskeletal Disorders and Wounds & Injuries, Cancer, Autoimmune Disorders, Others), By End-Users (Hospitals And Clinics, Research Centers, Others) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cellular Immunotherapy Global Market Report 2024 – By Therapy (Tumor-Infiltrating Lymphocyte (TIL) Therapy, Engineered T Cell Receptor (TCR) Therapy, Chimeric Antigen Receptor (CAR) T Cell Therapy, Natural Killer (NK) Cell Therapy), By Primary Indication (B-cell Malignancies, Prostate Cancer, Renal Cell Carcinoma, Liver Cancer, Non-Hodgkin lymphoma, Other Primary Indications), By Application (Prostate Cancer, Breast Cancer, Skin Cancer, Ovarian Cancer, Brain Tumor, Lung Cancer, Other Applications ) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cell and Gene Therapy Global Market Report 2024 – By Product (Cell Therapy, Gene Therapy), By Application (Oncology, Neurological Disorders, Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Cellular or Mobile Telephone Services Global Market Report 2024 – By Type (Basic Communication, Value-Added), By Service (3G Services, 4G Services, 5G Services), By End User (Manufacturing, Energy And Utilities, Media And Entertainment, It And Telecom, Transportation And Logistics, Healthcare) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the cell viability assays market?

Cell viability assays are methods used to determine the ability of cells, tissues, or organs to maintain or recover a state of survival. Cell viability assays are used to evaluate the best growth conditions for cells in culture in response to external stimuli, chemicals, and medicinal treatments when determining optimal growth conditions in cell culture. For further insights on the cell viability assays market, request a sample here

How will the cell viability assays market drivers and restraints affect the cell viability assays market dynamics? What forces will shape the cell viability assays industry going forward?

The cell viability assays market major growth driver - Role Of Cell-Based Therapeutics In Driving The Growth Of The Cell Viability Assays Market. For further insights on the cell viability assays market, request a sample here

What is the forecast market size or the forecast market value of the cell viability assays market?

The cell viability assays market size has grown rapidly in recent years. It will grow from $1.41 billion in 2023 to $1.56 billion in 2024 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to increased investment in cancer research, growth in pharmaceutical R&D expenditure, growth in the biotechnology sector, increased advancements in cell culture techniques, rise in demand for stem cell research, rise in the need for toxicity testing, rise in the utilization of real time cell analysis systems, rise in the number of CROs (contract research organizations). The cell viability assays market size is expected to see rapid growth in the next few years. It will grow to $2.34 billion in 2028 at a compound annual growth rate (CAGR) of 10.6 The growth in the forecast period can be attributed to increasing demand for personalized medicine, rise in government funding for cell based research, increasing focus on precision medicine, growth in stem cell research and applications, increasing availability of automated cell viability analyzers, rise in the incidence of infectious diseases, increasing focus on improving assay accuracy and sensitivity, increasing awareness about the benefits of cell viability assays, rise in the development of organ on a chip technologies, increasing demand for regenerative medicine. Major trends in the forecast period include advancement in high throughput screening methods, implementation of AI and machine learning algorithms, development of real time monitoring systems, adoption of automated liquid handling systems, development of multiplex assays to simultaneously measure cell viability, adoption of more sustainable and eco friendly reagents, development of user friendly assay kits, advancement in electrochemical assays, implementation of scalable cell viability assays, development of assays compatible with primary cells and stem cells. For further insights on the cell viability assays market, request a sample here

How is the cell viability assays market segmented?

The cell viability assays market is segmented
1) By Product: Consumables, Instruments
2) By Application: Basic Research, Stem Cell Research, Drug Discovery And Development, Clinical And Diagnostic Applications, Other Applications
3) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Hospital And Diagnostic Laboratories, Other End-UsersFor further insights on the cell viability assays market, request a sample here

Which region has the largest share of the cell viability assays market? What are the other regions covered in the report?

North America was the largest region in the cell viability assays market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell viability assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the cell viability assays market, request a sample here.

Who are the major players in the cell viability assays market?

Major companies operating in the cell viability assays market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson, and Company, Agilent Technologies Inc., Lonza Group Ltd., PerkinElmer Inc., Sartorius AG, Charles River Laboratories, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Beckman Coulter Inc., Promega Corporation, Abcam Limited, MP Biomedicals, Cayman Chemical Company, Cell Signaling Technology Inc. , Enzo Biochem Inc., Creative Bioarray, Abnova Corporation, Biotium, Canvax, Nexcelom Bioscience LLC, G-Biosciences, AAT Bioquest Inc. For further insights on the cell viability assays market, request a sample here.

What are the key trends in the cell viability assays market?

Major trend in the cell viability assays market - Innovative Cell Screening Technologies Revolutionize Drug Discovery. For further insights on the cell viability assays market, request a sample here.

What are the major opportunities in the cell viability assays market? What are the strategies for the cell viability assays market?

For detailed insights on the major opportunities and strategies in the cell viability assays market, request a sample here.

How does the cell viability assays market relate to the overall economy and other similar markets?

For detailed insights on cell viability assays market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the cell viability assays industry?

For detailed insights on the mergers and acquisitions in the cell viability assays industry, request a sample here.

What are the key dynamics influencing the cell viability assays market growth? SWOT analysis of the cell viability assays market.

For detailed insights on the key dynamics influencing the cell viability assays market growth and SWOT analysis of the cell viability assays industry, request a sample here.